IMCCNasdaqMedicinal Chemicals & Botanical ProductsFiscal year ends December 31

IM Cannabis Corp.

Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 20-F on Mar 30, 2026

$1.50+0.11 (+7.91%)

Close on Oct 19, 2026

IM Cannabis Corp. revenue by segment

Annual Quarterly TTM

By business segment

By product or service

By region

From the segment and revenue-disaggregation notes of IM Cannabis's 10-K and 10-Q filings (XBRL). Fourth-quarter figures are the fiscal year less the first nine months. Segment names follow the company's own labels and can change when it reorganizes.